CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: quercetin 3-O-beta-D-glucopyranoside
Accession: CHEBI:68352
browse the term
Definition: A quercetin O-glucoside that is quercetin with a beta-D-glucosyl residue attached at position 3. Isolated from Lepisorus contortus, it exhibits antineoplastic activityand has been found to decrease the rate of polymerization and sickling of red blood cells
Synonyms: exact_synonym: 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl beta-D-glucopyranoside
related_synonym: 2-(3,4-Dihidroxyphenyl)-3-(beta-D-glucofuranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one; 2-(3,4-dihydroxyphenyl)-3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one; Formula=C21H20O12; InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15-,17+,18-,21+/m1/s1; InChIKey=OVSQVDMCBVZWGM-QSOFNFLRSA-N; Isoquercitrin; Isotrifoliin; SMILES=OC[C@H]1O[C@@H](OC2=C(OC3=CC(O)=CC(O)=C3C2=O)C2=CC=C(O)C(O)=C2)[C@H](O)[C@@H](O)[C@@H]1O; isoquercetin
xref: CAS:21637-25-2; CAS:482-35-9; HMDB:HMDB0037362; KEGG:C05623; KNApSAcK:C00005373; LINCS:LSM-5818
xref_mesh: MESH:C016527
xref: PDBeChem:HW2; PMID:21261296; PMID:23856528; PMID:28702430; PMID:29141065; PMID:29317330; PMID:29852784; PMID:30365939; PMID:30652973; PMID:30817903; PMID:31063809; PMID:31271108; PMID:31315526; PMID:31441715; PMID:31500646; PMID:31577306; PMID:31639004; PMID:31677037; PMID:31679851; PMID:31712059; PMID:31715232; PMID:31844103; PMID:31870463; Reaxys:100989; Wikipedia:Isoquercetin
cyclic_relationship: is_conjugate_acid_of CHEBI:144437
G
Acat2
acetyl-CoA acetyltransferase 2
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of ACAT2 mRNA
CTD
PMID:18032389
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
G
Akr7a3
aldo-keto reductase family 7 member A3
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of AKR7A3 mRNA
CTD
PMID:20033131
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
G
Apoa1
apolipoprotein A1
increases secretion
ISO
isoquercitrin results in increased secretion of APOA1 protein
CTD
PMID:24963805
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Atf6
activating transcription factor 6
increases expression
EXP
isoquercitrin results in increased expression of ATF6 mRNA
CTD
PMID:30365939
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atxn2
ataxin 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of ATXN2 mRNA]
CTD
PMID:25129099
NCBI chr12:34,754,132...34,851,175
Ensembl chr12:34,754,137...34,851,479
G
Atxn3
ataxin 3
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of ATXN3 mRNA]
CTD
PMID:25129099
NCBI chr 6:121,072,228...121,107,902
Ensembl chr 6:121,074,448...121,107,902
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
isoquercitrin results in decreased expression of BCL2 mRNA
CTD
PMID:30597948
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
affects expression
ISO
isoquercitrin affects the expression of CASP3 mRNA
CTD
PMID:30597948
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
decreases expression
ISO
isoquercitrin results in decreased expression of CASP8 mRNA
CTD
PMID:30597948
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Cat
catalase
multiple interactions
EXP
[Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid co-treated with isoquercitrin analog] results in increased expression of CAT mRNA; isoquercitrin inhibits the reaction [Streptozocin results in decreased activity of CAT protein]
CTD
PMID:30298849 PMID:30817903
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA]
CTD
PMID:21295105
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
EXP
isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein]
CTD
PMID:14654164
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA]
CTD
PMID:21295105
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:104,010,680...104,019,050
G
Ctnnb1
catenin beta 1
affects expression
ISO
isoquercitrin affects the expression of CTNNB1 mRNA
CTD
PMID:30597948
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CXCL2 protein]
CTD
PMID:14654164
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity multiple interactions
ISO EXP
isoquercitrin results in decreased activity of CYP1A1 protein [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A1 mRNA
CTD
PMID:16271822 PMID:20033131
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA
CTD
PMID:20033131
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
isoquercitrin results in decreased activity of CYP1B1 protein
CTD
PMID:16271822
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of CYP2B2 mRNA]
CTD
PMID:20033131
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp51
cytochrome P450, family 51
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of CYP51A1 mRNA
CTD
PMID:18032389
NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,036,865...30,055,410 Ensembl chr 6:30,036,865...30,055,410
G
Dhcr7
7-dehydrocholesterol reductase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of DHCR7 mRNA
CTD
PMID:18032389
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Egf
epidermal growth factor
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein]
CTD
PMID:26109002
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]
CTD
PMID:26109002
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Egln1
egl-9 family hypoxia-inducible factor 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of EGLN1 mRNA]
CTD
PMID:25129099
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of FDFT1 mRNA
CTD
PMID:18032389
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
G
Fdps
farnesyl diphosphate synthase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of FDPS mRNA
CTD
PMID:18032389
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
[isoquercitrin analog co-treated with Propylthiouracil] results in decreased expression of FOS mRNA
CTD
PMID:31068541
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Gpx2
glutathione peroxidase 2
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GPX2 mRNA
CTD
PMID:20033131
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gria3
glutamate ionotropic receptor AMPA type subunit 3
multiple interactions
EXP
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of GRIA3 mRNA]
CTD
PMID:31068541
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
G
Gsta5
glutathione S-transferase alpha 5
multiple interactions
EXP
[isoquercitrin co-treated with oxfendazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTA5 mRNA]
CTD
PMID:20033131 PMID:20045035
NCBI chr 8:87,985,768...87,997,766
Ensembl chr 8:79,105,661...79,117,472
G
Gstm1
glutathione S-transferase mu 1
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GSTM1 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA]
CTD
PMID:20033131 PMID:20045035
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of HMGCR mRNA
CTD
PMID:18032389
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of HMGCS1 mRNA
CTD
PMID:18032389
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:51,649,497...51,667,100
G
Hmox1
heme oxygenase 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [beta-Naphthoflavone results in increased expression of HMOX1 protein]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of HMOX1 mRNA]
CTD
PMID:21295105 PMID:30817903
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Ibsp
integrin-binding sialoprotein
increases expression
EXP
isoquercitrin results in increased expression of IBSP mRNA
CTD
PMID:30365939
NCBI chr14:5,439,825...5,452,570
Ensembl chr14:5,439,829...5,452,693
G
Il1a
interleukin 1 alpha
multiple interactions
EXP
[isoquercitrin analog co-treated with Propylthiouracil] results in increased expression of IL1A mRNA; [isoquercitrin co-treated with Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IL1A mRNA
CTD
PMID:21295105 PMID:31068541
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of IL1B mRNA]
CTD
PMID:30817903
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of IL6 mRNA]
CTD
PMID:30817903
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Ins1
insulin 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of INS1 protein]
CTD
PMID:30817903
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
G
Insig1
insulin induced gene 1
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of INSIG1 mRNA
CTD
PMID:18032389
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Jak1
Janus kinase 1
increases expression
ISO
isoquercitrin results in increased expression of JAK1 mRNA
CTD
PMID:30597948
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
G
Jak2
Janus kinase 2
increases expression
ISO
isoquercitrin results in increased expression of JAK2 mRNA
CTD
PMID:30597948
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in decreased expression of KEAP1 mRNA]
CTD
PMID:30817903
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Lct
lactase
multiple interactions
EXP
[migalastat results in decreased activity of LCT protein] which results in decreased hydrolysis of isoquercitrin
CTD
PMID:12663055
NCBI chr13:39,781,929...39,824,456
Ensembl chr13:39,781,929...39,824,456
G
Ldlr
low density lipoprotein receptor
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of LDLR mRNA
CTD
PMID:18032389
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]
CTD
PMID:26109002
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:26109002
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
affects expression
ISO
isoquercitrin affects the expression of MCL1 mRNA
CTD
PMID:30597948
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Me1
malic enzyme 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of ME1 mRNA]
CTD
PMID:20033131
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
isoquercitrin results in decreased expression of and results in decreased activity of MMP2 protein
CTD
PMID:18715546
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
isoquercitrin results in decreased expression of and results in decreased activity of MMP9 protein
CTD
PMID:18715546
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA]
CTD
PMID:30817903
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
EXP
[isoquercitrin analog co-treated with Propylthiouracil] results in decreased expression of NFKB1 mRNA
CTD
PMID:31068541
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NFKBIA mRNA]
CTD
PMID:20045035
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOS2 mRNA]
CTD
PMID:21295105
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of NQO1 mRNA; isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of NQO1 mRNA]
CTD
PMID:20033131 PMID:31068541
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
multiple interactions
EXP
[Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid co-treated with isoquercitrin analog] results in increased expression of NR3C2 mRNA
CTD
PMID:30298849
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
G
Nsf
N-ethylmaleimide sensitive factor, vesicle fusing ATPase
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of NSF mRNA]
CTD
PMID:25129099
NCBI chr10:88,727,912...88,857,375
Ensembl chr10:88,727,912...88,857,386
G
Nsg1
neuronal vesicle trafficking associated 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of NSG1 mRNA]
CTD
PMID:25129099
NCBI chr14:72,648,771...72,670,521
Ensembl chr14:72,648,741...72,670,514
G
Opa1
OPA1, mitochondrial dynamin like GTPase
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of OPA1 mRNA]
CTD
PMID:25129099
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
G
Otx2
orthodenticle homeobox 2
multiple interactions
EXP
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]
CTD
PMID:31068541
NCBI chr15:21,942,233...21,953,034
Ensembl chr15:21,943,191...21,953,416
G
Park7
Parkinsonism associated deglycase
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PARK7 mRNA]
CTD
PMID:25129099
NCBI chr 5:166,636,551...166,659,825
Ensembl chr 5:161,353,719...161,376,970
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
affects expression
ISO
isoquercitrin affects the expression of PIK3CA mRNA
CTD
PMID:30597948
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:115,174,984...115,249,032
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
increases expression
ISO
isoquercitrin results in increased expression of PIK3R1 mRNA
CTD
PMID:30597948
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:32,882,032...32,963,631
G
Ppid
peptidylprolyl isomerase D
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PPID mRNA]
CTD
PMID:25129099
NCBI chr 2:164,727,803...164,740,168
Ensembl chr 2:164,727,779...164,740,221
G
Prkn
parkin RBR E3 ubiquitin protein ligase
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PRKN mRNA]
CTD
PMID:25129099
NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:48,690,556...49,882,555
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA]; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 protein]; isoquercitrin inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of PTGS2 mRNA]
CTD
PMID:14654164 PMID:20045035 PMID:30817903
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptk2
protein tyrosine kinase 2
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein]
CTD
PMID:26109002
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Relb
RELB proto-oncogene, NF-kB subunit
increases expression
ISO
isoquercitrin results in increased expression of RELB mRNA
CTD
PMID:30597948
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Runx2
RUNX family transcription factor 2
increases expression
EXP
isoquercitrin results in increased expression of RUNX2 mRNA
CTD
PMID:30365939
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
G
Sc5d
sterol-C5-desaturase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SC5D mRNA
CTD
PMID:18032389
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
G
Serpine1
serpin family E member 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SERPINE1 mRNA]
CTD
PMID:20045035
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Slc5a1
solute carrier family 5 member 1
multiple interactions
ISO
isoquercitrin inhibits the reaction [SLC5A1 protein results in increased uptake of methylglucoside]
CTD
PMID:17495124
NCBI chr14:81,778,495...81,843,084
Ensembl chr14:77,553,843...77,618,547
G
Sqle
squalene epoxidase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SQLE mRNA
CTD
PMID:18032389
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Srebf2
sterol regulatory element binding transcription factor 2
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased cleavage of and results in increased activity of SREBF2 protein; [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SREBF2 mRNA; SREBF2 protein affects the susceptibility to [isoquercitrin co-treated with Hydrogen Peroxide]
CTD
PMID:18032389
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
G
Stat3
signal transducer and activator of transcription 3
increases expression
ISO
isoquercitrin results in increased expression of STAT3 mRNA
CTD
PMID:30597948
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Stat6
signal transducer and activator of transcription 6
increases expression
ISO
isoquercitrin results in increased expression of STAT6 mRNA
CTD
PMID:30597948
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Stub1
STIP1 homology and U-box containing protein 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of STUB1 mRNA]
CTD
PMID:25129099
NCBI chr10:14,850,765...14,853,046
Ensembl chr10:14,850,765...14,853,046
G
Th
tyrosine hydroxylase
multiple interactions
EXP
isoquercitrin promotes the reaction [Oxidopamine results in decreased expression of TH mRNA]
CTD
PMID:25129099
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
ISO
isoquercitrin results in increased expression of TIMP1 protein
CTD
PMID:18715546
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tnf
tumor necrosis factor
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TNF mRNA]; isoquercitrin inhibits the reaction [Carrageenan results in increased expression of TNF protein]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of TNF mRNA]
CTD
PMID:14654164 PMID:21295105 PMID:30817903
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TNFRSF1A protein]
CTD
PMID:21295105
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tp53
tumor protein p53
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of TP53 mRNA]
CTD
PMID:30817903
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Tradd
TNFRSF1A-associated via death domain
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TRADD protein]
CTD
PMID:21295105
NCBI chr19:33,136,148...33,142,714
Ensembl chr19:33,136,138...33,142,638
G
Txn1
thioredoxin 1
multiple interactions
EXP
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of TXN1 mRNA]
CTD
PMID:31068541
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629
G
Tyk2
tyrosine kinase 2
affects expression
ISO
isoquercitrin affects the expression of TYK2 mRNA
CTD
PMID:30597948
NCBI chr 8:19,641,881...19,667,157
Ensembl chr 8:19,641,884...19,667,044
G
Uchl1
ubiquitin C-terminal hydrolase L1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of UCHL1 mRNA]
CTD
PMID:25129099
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all